PepGen Inc. (PEPG)
3.17
-0.04
(-1.25%)
USD |
NASDAQ |
Sep 09, 16:00
3.13
-0.04
(-1.26%)
After-Hours: 16:48
PepGen Enterprise Value : 121.18M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 121.18M |
| September 04, 2026 | 114.25M |
| September 03, 2026 | 119.10M |
| September 02, 2026 | 119.10M |
| September 01, 2026 | 114.94M |
| August 31, 2026 | 105.94M |
| August 28, 2026 | 112.17M |
| August 27, 2026 | 111.48M |
| August 26, 2026 | 121.87M |
| August 25, 2026 | 136.07M |
| August 24, 2026 | 119.79M |
| August 21, 2026 | 116.33M |
| August 20, 2026 | 109.06M |
| August 19, 2026 | 110.10M |
| August 18, 2026 | 100.40M |
| August 17, 2026 | 109.40M |
| August 14, 2026 | 105.94M |
| August 13, 2026 | 105.25M |
| August 12, 2026 | 99.71M |
| August 11, 2026 | 99.71M |
| August 10, 2026 | 105.94M |
| August 07, 2026 | 96.24M |
| August 06, 2026 | 65.77M |
| August 05, 2026 | 35.99M |
| August 04, 2026 | 32.53M |
| Date | Value |
|---|---|
| August 03, 2026 | 29.06M |
| July 31, 2026 | 20.75M |
| July 30, 2026 | 22.14M |
| July 29, 2026 | 17.29M |
| July 28, 2026 | 25.60M |
| July 27, 2026 | 30.45M |
| July 24, 2026 | 32.53M |
| July 23, 2026 | 44.30M |
| July 22, 2026 | 31.83M |
| July 21, 2026 | 45.69M |
| July 20, 2026 | 51.23M |
| July 17, 2026 | 54.69M |
| July 16, 2026 | 54.69M |
| July 15, 2026 | 65.08M |
| July 14, 2026 | 67.85M |
| July 13, 2026 | 67.85M |
| July 10, 2026 | 60.92M |
| July 09, 2026 | 58.15M |
| July 08, 2026 | 36.68M |
| July 07, 2026 | 40.84M |
| July 06, 2026 | 29.76M |
| July 02, 2026 | 20.75M |
| July 01, 2026 | 24.21M |
| June 30, 2026 | 23.52M |
| June 29, 2026 | 7.377M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.79B |
| Oncolytics Biotech, Inc. | 96.67M |
| Sangamo Therapeutics, Inc. | 58.40M |
| Sarepta Therapeutics, Inc. | 2.469B |
| Anixa Biosciences, Inc. | 83.62M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.81M |
| Total Expenses (Quarterly) | 17.81M |
| EPS Diluted (Quarterly) | -0.2574 |
| Earnings Yield | -41.19% |
| Normalized Earnings Yield | -41.19 |